2024年普通高等学校招生全国统一考试模拟试题英语一衡水金卷先享题分科综合卷

2024年普通高等学校招生全国统一考试模拟试题英语一衡水金卷先享题分科综合卷正在持续更新，目前金太阳答案为大家整理了相关试题及答案，供大家查缺补漏，高效提升成绩。

31.What does the author talk about BookTok?A.BookTok can make books live forever.B.It became a main form of literary criticism.C.Many authors promote their books via BookTok.D.It makes previously published books popular again.Could a new treatment developed by the US company Lilly mean "the beginning of the end"of Alzheimer's?Could we even cure it some day?These are headlines and questions swirling (around after news of a newdrug,called donanemab,showed promising results in phase-3 trials.The brain science behind Alzheimer's is complex,but CT and MRI scans suggest that poisonous changesoccur in the brain,including the abnormal buildup of proteins called amyloid plaques and tau tangles.The damagestarts in the parts of the brain essential for forming memories but then spreads throughout the organ,with braintissue shrinking significantly.Developing treatments for Alzheimer's has been a challenge,with almost 20 years passing with no new drugs.But in the last year,two new ones have emerged:donanemab and lecanemab.Neither are cures or magic bullets forthe disease,but they do address key symptoms.They target the amyloid proteins that can accumulate in the brainand damage neurons,slowing down its progression.While this news is exciting,there are major caveats.One is whether it will ever become available on the NHS.The cost is estimated to be about f20,000 per person per year of treatment.Another is the serious side-effects:in the study,brain swelling occurred in 24%of participants and brainbleeding occurred in 31.4%on the drug compared with 13.6%in the placebo()group.There were also threedeaths during the trial.Part of the problem for me,as an academic,in assessing the drug is that the full results of the trial haven't yetbeen shared publicly or published in a peer-review journal.We cannot access the full data or examine the trial yet,and there is always a motivation for private companies to overstate the effectiveness of new drugs.Trial resultsneed to be assessed by an independent body of experts.While it is unlikely to change clinical practice until at least 2025,the news of donanemab is again anindication that science is continuing to make progress when it comes to treating the major causes of illness anddeath,even one related to the highly complex inner workings of the brain.So,there are caveats and the need forcaution,but these new drugs are indeed the grounds for that rare thing these days:hope.32.What can we learn about Alzheimer from the passage?A.There exists a new drug to cure it completely.B.Most people will develop Alzheimer when they are old.C.It is caused by the accumulation of some proteins in the brainD.It results from the loss of memories as people get older.33.What does the underlined word "caveats"mean in paragraph 4?A.Warnings.B.Discussions.C.Debates.D.Weaknesses.34.What is the problem of the new drug according to the author as an academic?A.It has the serious side-effects such as brain bleeding and deathsB.The effectiveness may be blown up without fair assessment.C.The cost of the new drug is out of reach for ordinary peopleD.There is no possibility for new drugs to be admitted into the NHS.35.What is the author's attitude towards the new drug?A.Approving.B.Doubtful.C.Unclear.D.Indifferent.英语试题第5页（共8页）